tiprankstipranks
Nanollose Ltd. (AU:NC6)
ASX:NC6
Australian Market

Nanollose Ltd. (NC6) Price & Analysis

3 Followers

NC6 Stock Chart & Stats

AU$0.05
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.05
AU$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Low Leverage / Limited DebtLow absolute debt levels provide durable financial flexibility, reducing near-term refinancing risk and giving management runway to prioritise product development and commercialisation. This buffer supports operations during continued R&D and helps preserve optionality for strategic partnerships or scaling if revenue traction improves.
Improving Free Cash Flow TrendA reduction in cash burn between FY2024 and FY2025 signals operational progress toward lower funding intensity. If sustained, this trend materially extends runway, reduces near-term financing pressure, and increases the probability management can reach commercialization milestones without dilutive capital over the next several months.
Distinct Sustainable Material TechnologyThe company’s microbial cellulose addresses structural demand for sustainable textile inputs and can differentiate via a plant-free route. This technology aligns with long-term ESG-driven procurement trends and gives potential strategic value to brand partners and manufacturers seeking lower-impact materials, supporting durable market relevance if scaled.
Bears Say
Persistent Losses And Zero RevenueSustained losses combined with revenue falling to zero undermine proof of commercial traction and place the business on a financing-dependent path. Without recurring revenue, operating losses will likely persist, forcing access to external capital and raising execution risk for commercial roll-out and scaling over the next 2-6 months.
Weak Cash Generation / Ongoing Cash BurnConsistently negative operating and free cash flows indicate the business currently consumes cash to operate rather than self-funding growth. This structural cash burn increases dependency on external financing, risks dilution, and constrains investment in manufacturing or commercial partnerships essential for durable scale-up.
Revenue Volatility And Margin DeteriorationHigh revenue variability and worsening margins make unit economics uncertain and impede forecasting, partner commitments, and scaling decisions. This structural uncertainty weakens the firm’s ability to convert technology into profitable product lines and raises execution risk for achieving sustainable margins over the medium term.

Nanollose Ltd. News

NC6 FAQ

What was Nanollose Ltd.’s price range in the past 12 months?
Nanollose Ltd. lowest share price was AU$0.03 and its highest was AU$0.09 in the past 12 months.
    What is Nanollose Ltd.’s market cap?
    Nanollose Ltd.’s market cap is AU$20.61M.
      When is Nanollose Ltd.’s upcoming earnings report date?
      Nanollose Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 154 days.
        How were Nanollose Ltd.’s earnings last quarter?
        Nanollose Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
          Is Nanollose Ltd. overvalued?
          According to Wall Street analysts Nanollose Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Nanollose Ltd. pay dividends?
            Nanollose Ltd. does not currently pay dividends.
            What is Nanollose Ltd.’s EPS estimate?
            Nanollose Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Nanollose Ltd. have?
            Nanollose Ltd. has 327,066,350 shares outstanding.
              What happened to Nanollose Ltd.’s price movement after its last earnings report?
              Nanollose Ltd. reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.389%.
                Which hedge fund is a major shareholder of Nanollose Ltd.?
                Currently, no hedge funds are holding shares in AU:NC6
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Nanollose Ltd. Stock Smart Score

                  6
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  188.88%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -1964.93%
                  Trailing 12-Months
                  Asset Growth
                  -23.63%
                  Trailing 12-Months

                  Company Description

                  Nanollose Ltd.

                  Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre; and Jelli Grow, an alternative seed germination and plant growing material. Its products are used in textiles, nonwoven fabric, and other industries. The company was incorporated in 2014 and is based in Nedlands, Australia.

                  Nanollose Ltd. (NC6) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Prescient Therapeutics Limited
                  AnteoTech Ltd
                  Regeneus Ltd.
                  AdAlta Ltd.
                  Arovella Therapeutics Limited

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks